Copyright
©The Author(s) 2017.
World J Hepatol. May 18, 2017; 9(14): 677-688
Published online May 18, 2017. doi: 10.4254/wjh.v9.i14.677
Published online May 18, 2017. doi: 10.4254/wjh.v9.i14.677
Ref. | Patients (n) | IP-10 measurement method | Genotype (n) | Baseline IP-10 concentration, grouped by rapid virological response (pg/mL) | Overall RVR (n) | |||
RVR | Non-RVR | P-value | RVR | Non-RVR | ||||
Lagging et al[34] | 170 | ELISA (Quantikine, R and D systems, Minneapolis, MN, United States) | 1 (170) | 222 | 401 | P < 0.01 (median) | 33 | 137 |
1Fattovich et al[21] | 226 | ELISA (Quantikine, R and D systems, Minneapolis, MN, United States) | 1 (92) | 2.4 (± 0.28) | 2.6 (± 0.25) | P < 0.01 (log mean ± SD) | 172 | 108 |
2 (87) | 2.38 (± 0.31) | 2.3 (± 0.30) | P > 0.05 (log mean ± SD) | |||||
3 (47) | 2.45 (± 0.23) | 2.48 (± 0.39) | P > 0.05 (log mean ± SD) | |||||
Al-Ashgar et al[19] | 64 | ELISA (Quantikine, R and D systems, Minneapolis, MN, United States) | 4 (64) | 483.9 (± 261.6) | 609.9 (±424.3) | P > 0.05 (mean ± SD) | 12 | 52 |
- Citation: Neesgaard B, Ruhwald M, Weis N. Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review. World J Hepatol 2017; 9(14): 677-688
- URL: https://www.wjgnet.com/1948-5182/full/v9/i14/677.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i14.677